Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $319.1 million.

  • Tandem Diabetes Care's Cash & Current Investments fell 3257.81% to $319.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $319.1 million, marking a year-over-year decrease of 3257.81%. This contributed to the annual value of $438.3 million for FY2024, which is 632.23% down from last year.
  • Per Tandem Diabetes Care's latest filing, its Cash & Current Investments stood at $319.1 million for Q3 2025, which was down 3257.81% from $315.4 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Cash & Current Investments ranged from a high of $635.4 million in Q1 2022 and a low of $315.4 million during Q2 2025
  • In the last 5 years, Tandem Diabetes Care's Cash & Current Investments had a median value of $507.2 million in 2023 and averaged $505.4 million.
  • Per our database at Business Quant, Tandem Diabetes Care's Cash & Current Investments skyrocketed by 22048.15% in 2021 and then tumbled by 3257.81% in 2025.
  • Over the past 5 years, Tandem Diabetes Care's Cash & Current Investments (Quarter) stood at $623.8 million in 2021, then decreased by 1.11% to $616.9 million in 2022, then dropped by 24.15% to $467.9 million in 2023, then decreased by 6.32% to $438.3 million in 2024, then fell by 27.2% to $319.1 million in 2025.
  • Its last three reported values are $319.1 million in Q3 2025, $315.4 million for Q2 2025, and $368.6 million during Q1 2025.